Creo Medical Group PLC (CREO) — Working Capital to Net Assets Ratio
Creo Medical Group PLC (CREO) has a Working Capital to Net Assets ratio of 42.2% as of June 2025. Working capital of GBX25.70 Million (current assets of GBX31.70 Million minus current liabilities of GBX6.00 Million) is measured against net assets of GBX60.90 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Creo Medical Group PLC balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Creo Medical Group PLC Working Capital to Net Assets (2014–2024)
This chart shows how Creo Medical Group PLC's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2014 to 2024. As of June 2025, the ratio stands at 42.2%, reflecting working capital of GBX25.70 Million against net assets of GBX60.90 Million GBX. Check CREO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Creo Medical Group PLC (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Creo Medical Group PLC from 2014 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Creo Medical Group PLC market cap and net worth.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 84.7% | GBX35.90 Million | GBX42.40 Million | GBX56.40 Million | GBX20.50 Million | ▲ +37.8 pp |
| 2023 | 46.8% | GBX28.00 Million | GBX59.80 Million | GBX37.90 Million | GBX9.90 Million | ▲ +14.0 pp |
| 2022 | 32.8% | GBX16.20 Million | GBX49.40 Million | GBX33.69 Million | GBX17.48 Million | ▼ -23.7 pp |
| 2021 | 56.5% | GBX41.43 Million | GBX73.32 Million | GBX61.17 Million | GBX19.74 Million | ▼ -9.5 pp |
| 2020 | 66.0% | GBX41.44 Million | GBX62.81 Million | GBX59.47 Million | GBX18.03 Million | ▼ -32.0 pp |
| 2019 | 98.0% | GBX81.04 Million | GBX82.66 Million | GBX86.09 Million | GBX5.06 Million | ▼ -0.2 pp |
| 2018 | 98.2% | GBX46.87 Million | GBX47.71 Million | GBX48.51 Million | GBX1.64 Million | ▲ +4.5 pp |
| 2018 | 93.7% | GBX6.87 Million | GBX7.33 Million | GBX8.75 Million | GBX1.88 Million | ▼ -3.9 pp |
| 2017 | 97.6% | GBX14.30 Million | GBX14.65 Million | GBX15.77 Million | GBX1.47 Million | ▲ +13.5 pp |
| 2016 | 84.2% | GBX1.37 Million | GBX1.63 Million | GBX2.14 Million | GBX773.77K | ▼ -9.8 pp |
| 2016 | 94.0% | GBX3.03 Million | GBX3.22 Million | GBX3.54 Million | GBX512.38K | ▲ +10.8 pp |
| 2015 | 83.2% | GBX622.38K | GBX748.41K | GBX918.37K | GBX295.98K | ▼ -6.7 pp |
| 2014 | 89.9% | GBX1.24 Million | GBX1.37 Million | GBX1.49 Million | GBX250.20K | — |